Tony Mok Shu Kam - Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong

基本信息

Career Trajectory

Bio

Professor Tony Mok focuses on biomarker and molecular targeted therapy in lung cancer. He co-founded the Lung Cancer Research Group, and has led multiple multi-national studies that help establish the global standard on personalized medicine for lung cancer.

Research Interests

Papers共 1032 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Durvalumab with or Without Tremelimumab in Combination with Chemotherapy in First-Line Metastatic NSCLC: Five-Year Overall Survival Outcomes from the Phase 3 POSEIDON Trial

Solange Peters,Byoung Chul Cho,Alexander V. Luft,Jorge Alatorre-Alexander,Sarayut Lucien Geater,Konstantin Laktionov,Dmytro Trukhin,Sang-We Kim, Grygorii M. Ursol,Maen Hussein,Farah Louise Lim,Cheng-Ta Yang,Luiz Henrique Araujo,Haruhiro Saito,Niels Reinmuth, Caitlin Lowery,Helen Mann,Ross Stewart,Haiyi Jiang,Edward B. Garon,Tony Mok, Melissa L. Johnson

JOURNAL OF THORACIC ONCOLOGYno. 1 (2025): 76-93

Cited1Views0WOSBibtex

Cns Outcomes of Osimertinib Plus Chemotherapy in Patients with Egfr Mutation Positive Lung Cancer Beyond Osimertinib Progression

Wesley KY Wong,Kevin KS Mok, Giselle PC Tsui,Olivia H Chen,Herbert HF Loong,Landon L Chan, Kelvin Yan,Frankie Mo,Kirsty WC Lee,KC Lam,Florence ST Mok,David Johnson, Allen CC Chen, Benjamin Lam, Matthew Lee,Tony SK Mok,Molly SC Li

Clinical Lung Cancer（2025）

Cited0Views0WOSBibtex

Asian Thoracic Oncology Research Group Expert Consensus Statement on the Peri-Operative Management of Non-Small Cell Lung Cancer

Stephanie P. L. Saw,Wen-Zhao Zhong, Rui Fu,Molly S. C. Li,Yasushi Goto,Stephen B. Fox,Yasushi Yatabe,Boon-Hean Ong,Calvin S. H. Ng, David D. W. Lee, Pham Cam Phuong,In Kyu Park,James C. H. Yang,Masahiro Tsuboi,Lye Mun Tho,Thomas John,Hsao-Hsun Hsu,Daniel S. W. Tan,Tony S. K. Mok,Thanyanan Reungwetwattana, Navneet Singh

LUNG CANCER (2025)

Cited0Views0WOSBibtex

First-Line Lorlatinib Versus Crizotinib in Asian Patients with Advanced ALK-Positive NSCLC: Five-Year Outcomes from the CROWN Study

Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer (2025)

Cited0Views0WOSBibtex

The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials

Benjamin J Solomon,Daniel S W Tan,Gilberto de Castro,Manuel Cobo,Marina Chiara Garassino,Jun Zhang,Bruce E Johnson,Jay M Lee,Pilar Garrido, Andrew A Butler, Marc R Pelletier,Alexander Savchenko, Lexiang Ji,Jan C Brase, Rafael Caparica,David Demanse, Jincheng Wu, Claudia Bossen,Tony Mok

Cancer research communicationsno. 4 (2025): 632-646

Cited0Views0WOSBibtex

Concomitant Usage of H1-Antihistamines and Immune Checkpoint Inhibitors on Cancer Patient Survival

Yin Leung,Terry Cheuk-Fung Yip,Grace Lai-Hung Wong,Vincent Wai-Sun Wong,Vicki Wing-Ki Hui,Tony Shu-Kam Mok,Henry Lik-Yuen Chan,Stephen Lam Chan,Rashid Nok-Shun Lui

CANCER MEDICINE（2025）

Cited0Views0WOSBibtex

Supplemental Table S5 from D3S-001, a KRAS G12C Inhibitor with Rapid Target Engagement Kinetics, Overcomes Nucleotide Cycling, and Demonstrates Robust Preclinical and Clinical Activities

Jing Zhang,Sun Min Lim,Mi Ra Yu,Cheng Chen, Jia Wang,Wenqian Wang,Haopeng Rui,Jingtao Lu,Shun Lu,Tony Mok,Zhi Jian Chen,Byoung Chul Cho

crossref（2024）

Cited0Views0Bibtex

Lung Cancer Research and Treatment: Global Perspectives and Strategic Calls to Action

M.-L. Meyer,S. Peters,T.S. Mok, S. Lam, P.-C. Yang, C. Aggarwal,J. Brahmer,R. Dziadziuszko,E. Felip, A. Ferris,P.M. Forde,J. Gray, L. Gros, B. Halmos,R. Herbst, P.A. Jänne,B.E. Johnson, K. Kelly, N.B. Leighl,S. Liu

Annals of Oncology (2024)

Cited0Views0WOSBibtex

Supplemental Figure S4 from D3S-001, a KRAS G12C Inhibitor with Rapid Target Engagement Kinetics, Overcomes Nucleotide Cycling, and Demonstrates Robust Preclinical and Clinical Activities

Jing Zhang,Sun Min Lim,Mi Ra Yu,Cheng Chen, Jia Wang,Wenqian Wang,Haopeng Rui,Jingtao Lu,Shun Lu,Tony Mok,Zhi Jian Chen,Byoung Chul Cho

crossref（2024）

Cited0Views0Bibtex

689P Patterns of Disease Progression and Efficacy of Local Ablative Therapy among Patients with Metastatic EGFR-mutation Positive Non-Small Cell Lung Cancer Treated with First-Line Osimertinib

C. C. A. Chen, O. H. Chen,K. Mok,K. C. Lam,W. C. K. Lee,S. T. F. Mok, T. Y. J. Ng, D. Johnson,L. L. Chan, K. C. K. Yan,W. Wong,B. Lam, M. P. Lee,T. S. K. Mok, S. C. M. Li

ANNALS OF ONCOLOGY (2024)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn